首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Health economics review

缩写:

ISSN:2191-1991

e-ISSN:2191-1991

IF/分区:3.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引870
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Japheth Osotsi Awiti Japheth Osotsi Awiti
The paper investigates the effect of adequate use of prenatal care on birth weight in Kenya using data from the Kenya Demographic and Health Survey of 2008-2009 together with additional administrative data. Both a single-level model and a m...
Sarah Neubauer,Mary Cifaldi,Thomas Mittendorf et al. Sarah Neubauer et al.
Objective: To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in rheumatoid arthritis (RA) patients treated in Germany. ...
Andrea Lebioda,David Gasche,Franz-Werner Dippel et al. Andrea Lebioda et al.
Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal Joint Committee (G-BA). In ...
Xi Chen Xi Chen
Background: Blood collection following nonstandard operations largely increases the risks of infectious diseases through cross-contamination. Commercial plasma donation and the resulting HIV/AIDS and hepatitis C epidemics...
Henry Bailey,Paul Kind,Althea La Foucade Henry Bailey
Background: EQ-5D-3L valuation studies continue to employ the MVH protocol or variants of MVH. One issue that has received attention is the selection of the states for direct valuation by respondents. Changes in the valua...
Corinna Hentschker,Roman Mennicken,Andreas Schmid Corinna Hentschker
The correct definition of the product market and of the geographic market is a prerequisite for assessing market structures in antitrust cases. For hospital markets, both dimensions are controversially discussed in the literature. Using dat...
Bjoern Schwander Bjoern Schwander
The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categoriz...
Ebenezer K Tetteh,Stephen Morris Ebenezer K Tetteh
Biologic drugs, as with all other medical technologies, are subject to a number of regulatory, marketing, reimbursement (financing) and other demand-restricting hurdles applied by healthcare payers. One example is the routine use of cost-ef...
Steffen Flessa,Anika Zembok Steffen Flessa
Background: Diabetes Mellitus Type II (T2DM) is a major and growing medical, social and economic burden in the East-Asian country of Cambodia. However, no economic modelling has been done to predict the number of cases an...
Stephan Eger,Jörg C Mahlich Stephan Eger
Objectives: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This stu...